EGFR and central nervous system cancer: Previous studies have shown that regulation of the EGFR pathway plays an important role in glioma progression [11], and certain EGFR genotypes may be related to glioblastoma risk, indicating that germline EGFR polymorphisms may have important implications in carcinogenesis of glioma [12].